Ataxia: Patient-reported outcomes
Patient-reported outcomes after stem cell therapy for Ataxia, based on 143 patients in our follow-up registry.
Updated ·
Overall patient-reported outcomes
Physical condition
reported physical improvement
78%
N = 136
Quality of life
reported quality-of-life improvement
76%
N = 135
Treatment satisfaction
satisfied with the treatment outcome
75%
N = 141
Reported change vs. before treatment
Worse No change Small Moderate Significant
| Symptom | Reported change vs. before treatment | Reported improvement |
|---|---|---|
| Speech (babbling for infants) | | 83% |
| Drooling | | 83% |
| Swallowing | | 83% |
| Fine hand movements | | 79% |
| Memory | | 78% |
| Muscle stiffness | | 77% |
| Coordination | | 76% |
| Weight loss | | 75% |
| Control of movement | | 75% |
| Tremors | | 75% |
| Fatigue | | 74% |
| Sleep disturbance | | 74% |
| Balance | | 74% |
| Low mood or anxiety | | 72% |
| Cognitive impairment | | 72% |
| Walking | | 68% |
About this data
Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.
